royal jelly and chemotherapy
Phase 3
Recruiting
- Conditions
- breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20231226060535N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Confirmed diagnosis of breast cancer by laboratory and clinical evidence
Hemoglobin > 8 g/dL
Hematocrit > 30%
SGOT serum level <3 times higher than normal
Bilirubin level less than 2 mg/dl
Creatinine less than 2mg/dl
Normal thyroid test result
Exclusion Criteria
Having an underlying and chronic active inflammatory disease such as: RA, COPD, unstable cardiovascular disease, lung diseases such as asthma, uncontrolled pain, severe infection, pregnancy, severe depression
Simultaneous use of drugs that can affect fatigue
Metastatic patients with poor performance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of symptoms of fatigue. Timepoint: Measurement of symptoms of fatigue before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires.;Severity of symptoms of weakness. Timepoint: Measurement of symptoms of weakness before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires.
- Secondary Outcome Measures
Name Time Method